Rani Therapeutics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Public

  • Employees
  • 163

Employees

  • Stock Symbol
  • RANI

Stock Symbol

  • Share Price
  • $3.14
  • (As of Friday Closing)

Rani Therapeutics General Information

Description

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing.

Contact Information

Website
www.ranitherapeutics.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 2051 Ringwood Avenue
  • San Jose, CA 95131
  • United States
+1 (408) 000-0000

Rani Therapeutics Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rani Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.14 $2.61 $1.82 - $8.38 $67.5M 25.9M 74.5K -$1.41

Rani Therapeutics Financials Summary

In Thousands,
USD 		TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 35,460 107,483 272,888
Revenue 0 0 2,717 462
EBITDA (69,378) (62,903) (52,173) (16,018)
Net Income (35,658) (30,588) (8,331) 0
Total Assets 70,436 108,027 124,207 79,415
Total Debt 30,282 30,214 0 3,771
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Rani Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rani Therapeutics‘s full profile, request access.

Request a free trial

Rani Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the developm
Drug Delivery
San Jose, CA
163 As of 2022
00000
0000 00000

000000

t enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqui
0000 00000000
New York, NY
00 As of 0000
0000
000000 - 000 0000

000000

, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo conseq
0000 00000000
Malvern, PA
00 As of 0000
00000
0000000000.
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rani Therapeutics Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oramed Pharmaceuticals Corporation New York, NY 00 0000 000000 - 000 0000
00000000 Formerly VC-backed Malvern, PA 00 00000 0000000000.
00000000 Formerly VC-backed Rockville, MD 0 000.00 000000000 000.00
000000 00000000000 Formerly PE-Backed South San Francisco, CA 00 00000 000000&0 00000
To view Rani Therapeutics’s complete competitors history, request access »

Rani Therapeutics Patents

  • 375

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 35

    Granted

  • 9

    Pending

  • 000

    Expiring in next 12 mo

Rani Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022226936-A1 Treatments for hemophilia a Pending 24-Feb-2021 000000000
CA-3211459-A1 Treatments for hemophilia a Pending 24-Feb-2021 000000000
US-20230088737-A1 Injection of a therapeutic formulation into a wall of the gastrointestinal tract Pending 18-Feb-2020 000000000
AU-2021221977-A1 Injection of a therapeutic formulation into a wall of the gastrointestinal tract Pending 18-Feb-2020 0000000000
CA-3170332-A1 Injection of a therapeutic formulation into a wall of the gastrointestinal tract Pending 18-Feb-2020 A61M31/002
To view Rani Therapeutics’s complete patent history, request access »

Rani Therapeutics Executive Team (12)

Name Title Board Seat Contact Info
Talat Imran Chief Executive Officer & Board Member
Svai Sanford Chief Financial Officer
Mir Hashim Ph.D Chief Scientific Officer
Kate McKinley Chief Business Officer
Collin Beloin Executive
You’re viewing 5 of 12 executive team members. Get the full list »

Rani Therapeutics Board Members (11)

Name Representing Role Since
Andrew Farquharson InCube Ventures Board Member 000 0000
Dennis Ausiello Ph.D Self Board Member 000 0000
Jean-Luc Butel Rani Therapeutics Board Member 000 0000
Laureen Debuono JD FLG Partners Board Member 000 0000
Lisa Rometty Rani Therapeutics Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Rani Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rani Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Rani Therapeutics‘s full profile, request access.

Request a free trial